NCT06084598View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

March 8, 2024

Study Completion Date

March 8, 2024

Conditions
Healthy Participants
Interventions
DRUG

BMS-986446

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (1)

90630

Local Institution - 0001, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06084598 - A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity | Biotech Hunter | Biotech Hunter